COc1ccccc1-c1cccc([C@@H]2C[C@H]3[C@H](CON3C)CN2S(=O)(=O)c2ccccc2C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?